CVS Health Valuation Overview

CVS -- USA Stock  

USD 79.39  0.43  0.54%

CVS Health shows prevailing Real Value of $83.3875 per share. The current price of the firm is $79.39. At this time the firm appears to be under valued. Macroaxis approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of 8.62% and Profit Margin of 1.61% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
CVS Health Market Cap
CVS Health Corporation is rated second in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 474.72 Billion. CVS Health retains roughly 78.67 Billion in market capitalization claiming about 17% of equities under Health Care Plans industry.
Capitalization  Revenue  Total debt  Valuation  Workforce
Horizon     30 Days    Login   to change
CVS Health Corporation is rated second in five year return category among related companies. It is rated below average in beta category among related companies totaling about  0.51  of Beta per Five Year Return. The ratio of Five Year Return to Beta for CVS Health Corporation is roughly  1.96 

Current Market Valuation

CVS Health Valuation Boundaries

Under Valued
September 20, 2018
Market Value
Real Value
Target Odds
CVS Health is not too risky asset. Calculation of real value of CVS Health is based on 1 month time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio1.84
Revenue Growth2.20%
Payout Ratio68.49%
Enterprise Value To Ebitda7.84
Enterprise Value To Revenue0.53
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.